<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Axonics Modulation Technologies, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Axonics Modulation Technologies, Inc.

    Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) is a medical technology company focused on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation (“SNM”) solutions. SNM therapy is primarily used to treat patients with overactive bladder (“OAB”), fecal incontinence (“FI”) and urinary retention (“UR”). Axonics currently has marketing approvals in Europe, Canada, and Australia for OAB, FI, and UR. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $400,000,000
    • SIC CODE
      3841
    • NIN CODE
      ####
    • LEADERSHIP
      Raymond W. Cohen
    • FOUNDED
      2012
    • EMPLOYEES
      51-100
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Proteon Therapeutics, Inc.

    Proteon Therapeutics, Inc.

    Proteon Therapeutics is working to deliver a new future for patients and families ...

    Proteon Therapeutics is working to deliver a ne...

    Filing Type:    PU
    Ekso Bionics Holdings, Inc.

    Ekso Bionics Holdings, Inc.

    Ekso BionicsÂŽ is a pioneer in the field of robotics. For over a decade we have be...

    Ekso BionicsÂŽ is a pioneer in the field of rob...

    Filing Type:    PU
    BioHealthonomics Inc.

    BioHealthonomics Inc.

    BioHealthonomics Inc. is a research and development biotechnology & healthcare com...

    BioHealthonomics Inc. is a research and develop...

    Amount Raised:    $35,800
    Fundraising Status:    EC
    Filing Type:    CF
    Harpoon Therapeutics, Inc.

    Harpoon Therapeutics, Inc.

    Harpoon Therapeutics is a clinical-stage immunotherapy company developing a novel ...

    Harpoon Therapeutics is a clinical-stage immuno...

    Filing Type:    PU
    argenx SE

    argenx SE

    argenx is a clinical-stage biotechnology company developing a deep pipeline of dif...

    argenx is a clinical-stage biotechnology compan...

    Filing Type:    PU
    Semler Scientific, Inc.

    Semler Scientific, Inc.

    Semler Scientific, Inc. is an emerging medical risk-assessment company whose diagn...

    Semler Scientific, Inc. is an emerging medical ...

    Filing Type:    PU
    DarioHealth Corp.

    DarioHealth Corp.

    DarioHealth Corp. (NASDAQ: DRIO) is a leading global Digital Therapeutics (DTx) co...

    DarioHealth Corp. (NASDAQ: DRIO) is a leading g...

    Filing Type:    PU
    Participant Assistive Products

    Participant Assistive Products

    We make affordable assistive products, starting with a groundbreaking supportive w...

    We make affordable assistive products, starting...

    Amount Raised:    $211,262.00
    Fundraising Status:    EC
    Filing Type:    CF
    Fonar Corporation

    Fonar Corporation

    Fonar Corporation, the MRI Specialist™, is the world’s leading developer and m...

    Fonar Corporation, the MRI Specialist™, is th...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.